Hyderabad-based Hetero Drugs has bagged the government’s 10-million anti-flu drug order. The company will supply nine million capsules of Oseltamivir, the generic version of Roche’s Tamiflu, to the government.
Industry officials estimate Hetero Drugs would earn INR30-35 crore from the order. The pharma company has the licence from Swiss drug major Roche to develop and sell the generic version of Tamiflu. Hetero Drugs pips bigger rivals, such as Cipla, Ranbaxy, Roche India and Natco, who also sent quotations to supply their drugs. The remaining order will be completed by mid-June. The company says it has adequate raw material and dedicated manufacturing blocks to make Oseltamivir in emergency situations, as per its pact with Roche. The company is expecting to bag additional drug orders worth at least $10 million (Rs 50 crore) from foreign governments. It is in talks with about 40-50 countries, which include Argentina, Columbia, Venezuela, Honduras, Thailand, the Philippines, Egypt, Saudi Arabia and over 10 countries in Africa. Following the global outbreak of H1N1 Influenza Flu, governments across the world are stockpiling Oseltamivir to combat the disease.